Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Loss |
| Beginning Balance (in shares) at Dec. 31, 2023 |
|
35,521
|
|
|
|
| Beginning Balance at Dec. 31, 2023 |
$ 1,981,420
|
$ 355
|
$ 16,760
|
$ 2,114,765
|
$ (150,460)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
79,965
|
|
|
79,965
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
| Cumulative translation adjustment |
(11,433)
|
|
|
|
(11,433)
|
| Issuance of common stock in connection with: |
|
|
|
|
|
| Exercise of options (in shares) |
|
106
|
|
|
|
| Exercise of options |
3,898
|
$ 1
|
3,897
|
|
|
| Restricted share grants, less net settled shares (in shares) |
|
70
|
|
|
|
| Restricted share grants, less net settled shares |
(8,306)
|
$ 1
|
(8,307)
|
|
|
| Share-based compensation |
8,812
|
|
8,812
|
|
|
| Ending Balance (in shares) at Mar. 31, 2024 |
|
35,697
|
|
|
|
| Ending Balance at Mar. 31, 2024 |
2,054,356
|
$ 357
|
21,162
|
2,194,730
|
(161,893)
|
| Beginning Balance (in shares) at Dec. 31, 2023 |
|
35,521
|
|
|
|
| Beginning Balance at Dec. 31, 2023 |
1,981,420
|
$ 355
|
16,760
|
2,114,765
|
(150,460)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
230,378
|
|
|
|
|
| Ending Balance (in shares) at Sep. 30, 2024 |
|
35,949
|
|
|
|
| Ending Balance at Sep. 30, 2024 |
2,252,199
|
$ 360
|
41,555
|
2,345,143
|
(134,859)
|
| Beginning Balance (in shares) at Mar. 31, 2024 |
|
35,697
|
|
|
|
| Beginning Balance at Mar. 31, 2024 |
2,054,356
|
$ 357
|
21,162
|
2,194,730
|
(161,893)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
83,947
|
|
|
83,947
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
| Cumulative translation adjustment |
(1,718)
|
|
|
|
(1,718)
|
| Issuance of common stock in connection with: |
|
|
|
|
|
| Exercise of options (in shares) |
|
180
|
|
|
|
| Exercise of options |
6,716
|
$ 2
|
6,714
|
|
|
| Restricted share grants, less net settled shares (in shares) |
|
25
|
|
|
|
| Restricted share grants, less net settled shares |
(3,210)
|
|
(3,210)
|
|
|
| Share-based compensation |
9,289
|
|
9,289
|
|
|
| Ending Balance (in shares) at Jun. 30, 2024 |
|
35,902
|
|
|
|
| Ending Balance at Jun. 30, 2024 |
2,149,380
|
$ 359
|
33,955
|
2,278,677
|
(163,611)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
66,466
|
|
|
66,466
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
| Cumulative translation adjustment |
28,752
|
|
|
|
28,752
|
| Issuance of common stock in connection with: |
|
|
|
|
|
| Restricted share grants, less net settled shares (in shares) |
|
47
|
|
|
|
| Restricted share grants, less net settled shares |
(2,273)
|
$ 1
|
(2,274)
|
|
|
| Share-based compensation |
9,874
|
|
9,874
|
|
|
| Ending Balance (in shares) at Sep. 30, 2024 |
|
35,949
|
|
|
|
| Ending Balance at Sep. 30, 2024 |
$ 2,252,199
|
$ 360
|
41,555
|
2,345,143
|
(134,859)
|
| Beginning Balance (in shares) at Dec. 31, 2024 |
35,913
|
35,913
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
$ 2,258,290
|
$ 359
|
39,650
|
2,394,853
|
(176,572)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
61,824
|
|
|
61,824
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
| Cumulative translation adjustment |
14,574
|
|
|
|
14,574
|
| Issuance of common stock in connection with: |
|
|
|
|
|
| Exercise of options (in shares) |
|
2
|
|
|
|
| Exercise of options |
80
|
|
80
|
|
|
| Restricted share grants, less net settled shares (in shares) |
|
67
|
|
|
|
| Restricted share grants, less net settled shares |
(7,207)
|
$ 1
|
(7,208)
|
|
|
| Purchase and retirement of common stock, including excise tax (in shares) |
|
(1,127)
|
|
|
|
| Purchase and retirement of common stock, including excise tax |
(187,676)
|
$ (11)
|
(187,665)
|
|
|
| Share-based compensation |
9,753
|
|
9,753
|
|
|
| Reclassification of negative additional paid-in capital |
0
|
|
145,390
|
(145,390)
|
|
| Ending Balance (in shares) at Mar. 31, 2025 |
|
34,855
|
|
|
|
| Ending Balance at Mar. 31, 2025 |
$ 2,149,638
|
$ 349
|
0
|
2,311,287
|
(161,998)
|
| Beginning Balance (in shares) at Dec. 31, 2024 |
35,913
|
35,913
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
$ 2,258,290
|
$ 359
|
39,650
|
2,394,853
|
(176,572)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
$ 216,340
|
|
|
|
|
| Ending Balance (in shares) at Sep. 30, 2025 |
31,346
|
31,346
|
|
|
|
| Ending Balance at Sep. 30, 2025 |
$ 1,749,655
|
$ 313
|
0
|
1,882,483
|
(133,141)
|
| Beginning Balance (in shares) at Mar. 31, 2025 |
|
34,855
|
|
|
|
| Beginning Balance at Mar. 31, 2025 |
2,149,638
|
$ 349
|
0
|
2,311,287
|
(161,998)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
71,698
|
|
|
71,698
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
| Cumulative translation adjustment |
33,773
|
|
|
|
33,773
|
| Issuance of common stock in connection with: |
|
|
|
|
|
| Exercise of options (in shares) |
|
18
|
|
|
|
| Exercise of options |
697
|
|
697
|
|
|
| Restricted share grants, less net settled shares (in shares) |
|
46
|
|
|
|
| Restricted share grants, less net settled shares |
(7,603)
|
|
(7,603)
|
|
|
| Purchase and retirement of common stock, including excise tax (in shares) |
|
(2,192)
|
|
|
|
| Purchase and retirement of common stock, including excise tax |
(358,240)
|
$ (22)
|
(358,218)
|
|
|
| Share-based compensation |
9,918
|
|
9,918
|
|
|
| Reclassification of negative additional paid-in capital |
0
|
|
355,206
|
(355,206)
|
|
| Ending Balance (in shares) at Jun. 30, 2025 |
|
32,727
|
|
|
|
| Ending Balance at Jun. 30, 2025 |
1,899,881
|
$ 327
|
0
|
2,027,779
|
(128,225)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income |
82,818
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
| Cumulative translation adjustment |
(4,916)
|
|
|
|
(4,916)
|
| Issuance of common stock in connection with: |
|
|
|
|
|
| Exercise of options (in shares) |
|
18
|
|
|
|
| Exercise of options |
610
|
|
610
|
|
|
| Restricted share grants, less net settled shares (in shares) |
|
27
|
|
|
|
| Restricted share grants, less net settled shares |
(1,417)
|
|
(1,417)
|
|
|
| Purchase and retirement of common stock, including excise tax (in shares) |
|
(1,426)
|
|
|
|
| Purchase and retirement of common stock, including excise tax |
(236,344)
|
$ (14)
|
(236,330)
|
|
|
| Share-based compensation |
9,023
|
|
9,023
|
|
|
| Reclassification of negative additional paid-in capital |
$ 0
|
|
228,114
|
(228,114)
|
|
| Ending Balance (in shares) at Sep. 30, 2025 |
31,346
|
31,346
|
|
|
|
| Ending Balance at Sep. 30, 2025 |
$ 1,749,655
|
$ 313
|
$ 0
|
$ 1,882,483
|
$ (133,141)
|